♥

Dr. Reddy's Laboratories Limited

ISIN : INE089A01023
NSE : DRREDDY
BSE : 500124
Face Value : 5
Industry : Pharmaceuticals & Drugs

EPS : 334.59
EPS (TTM) : 333.73
Price to Earning (P/E) : 3.42
Book Value : 1686.06
Price to Bookvalue (P/B) : 0.68
Dividend Yield : 3 %
Return on Equity (ROE) : 21.76 %
Return on Capital Employed (ROCE) : 26.86 %

Dr. Reddy's share price (02-Apr-2026)
National Stock Exchange NSE
Open / Close	0 - 0 NAN %
Low / High	0 - 0 NAN %
Trade Volume	0
52 Week Low / High	0 - 0 NAN %
Bombay Stock Exchange BSE
Open / Close	1190.5 - 1217.6 2.3 %
Low / High	1167.3 - 1222.15 4.7 %
Trade Volume	45,419
52 Week Low / High	1121.2 - 1377.95 22.9 %

YOU MAY ALSO LIKE

Low PE ratio stocks
Undervalued, low PE ratio stocks on Stock exchange NSE and BSE
Stock market course tutorial
Stock Market Investment Course explained in simple words.
High dividend stocks
High dividend yield stocks on Stock exchange NSE and BSE
CAGR Calculator
Check your investment returns using our CAGR / Investment Growth Calculator
How much money do you need to retire
Know how much money do you need to retire, before how much to invest ?
Share Market basics for beginners
Share Market jargons in simple terms

Consolidated Standalone

CONSOLIDATED QUARTERLY RESULT FOR DR. REDDY'S LABORATORIES LIMITED

Date End	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
No of months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months
Net Sales	54749	52329	63318	67898	63152	67579	69026	72368	71138	76961
Total Income	55968	60868	63726	68485	64537	69319	72176	74530	73113	78833
Total Expenditure	50239	42917	44329	48513	47813	46958	48943	52137	52826	55662
Other Income	1219	8539	408	587	1385	1740	3150	2162	1975	1872
Operating Profit	5729	17951	19397	19972	16724	22361	23233	22393	20287	23171
Interest	315	347	309	418	354	371	353	394	593	598
PBDT	5414	17604	19088	19554	16370	21990	22880	21999	19694	22573
Depreciation	2930	3018	3092	3237	3155	3533	3755	3735	3677	3806
Profit Before Tax	2484	14586	15996	16317	13215	18457	19125	18264	16017	18767
Tax	1619	2790	4994	3938	3690	4450	4345	4482	2954	4902
Profit After Tax	865	11796	11002	12379	9525	14007	14780	13782	13063	13865
Net Profit	865	11796	11002	12379	9525	14007	14780	13782	13063	13865
Equity Capital	832	832	832	833	833	833	834	834	834	834
Face Value (IN RS)	5	5	5	5	5	5	5	5	5	5
Calculated EPS	5.83	71.45	66.96	74.66	57.63	84.33	88.86	82.79	78.53	83.48
Diluted Eps After Extraordinary Items	5.83	71.49	66.98	74.76	57.68	84.36	88.91	82.81	78.53	83.48
Diluted Eps Before Extraordinary Items	5.83	71.49	66.98	74.76	57.68	84.36	88.91	82.81	78.53	83.48

STANDALONE QUARTERLY RESULT FOR DR. REDDY'S LABORATORIES LIMITED

Date End	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
No of months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months
Net Sales	36687	36306	48803	38976	45540	54373	48387	41030	51048	58412
Total Income	37834	40340	49983	39490	46688	56709	50618	43306	53175	60590
Total Expenditure	29988	30511	30775	32225	34929	32096	32096	34467	37262	38882
Other Income	1147	4034	1180	514	1148	2336	2231	2276	2127	2178
Operating Profit	7846	9829	19208	7265	11759	24613	18522	8839	15913	21708
Interest	127	98	17	28	26	45	58	56	59	71
PBDT	7719	9731	19191	7237	11733	24568	18464	8783	15854	21637
Depreciation	2052	2215	2262	2388	2367	2372	2458	2464	2462	2498
Profit Before Tax	5667	7516	16929	4849	9366	22196	16006	6319	13392	19139
Tax	1470	2521	5766	1603	2642	5802	4080	1567	3044	4967
Profit After Tax	4197	4995	11163	3246	6724	16394	11926	4752	10348	14172
Net Profit	4197	4995	11163	3246	6724	16394	11926	4752	10348	14172
Equity Capital	832	832	832	833	833	833	834	834	834	834
Face Value (IN RS)	5	5	5	5	5	5	5	5	5	5
Calculated EPS	25.22	30.02	67.09	19.48	40.36	98.4	71.5	28.49	62.04	84.96
Diluted Eps After Extraordinary Items	25.24	30.03	67.1	19.5	40.41	98.45	71.54	28.5	62.04	84.97
Diluted Eps Before Extraordinary Items	25.24	30.03	67.1	19.5	40.41	98.45	71.54	28.5	62.04	84.97

Consolidated Standalone

CONSOLIDATED ANNUAL RESULT FOR DR. REDDY'S LABORATORIES LIMITED

Date End	Mar 2022	Mar 2023	Mar 2024
No of months	12 months	12 months	12 months
Net Sales	215452	246697	280111
Total Income	220296	257252	289054
Total Expenditure	177775	183207	200780
Other Income	4844	10555	8943
Operating Profit	42521	74045	88274
Interest	958	1428	1711
PBDT	41563	72617	86563
Depreciation	11652	12502	14700
Profit Before Tax	29911	60115	71863
Tax	8789	15412	16231
Profit After Tax	21122	44703	55632
Net Profit	21122	44703	55632
Equity Capital	832	833	834
Face Value (IN RS)	5	5	5
Reserves	191292	232028	281714
Calculated EPS	131.16	270.55	334.41
Diluted Eps After Extraordinary Items	131.21	270.9	334.59
Diluted Eps Before Extraordinary Items	131.21	270.9	334.59

STANDALONE ANNUAL RESULT FOR DR. REDDY'S LABORATORIES LIMITED

Date End	Mar 2022	Mar 2023	Mar 2024
No of months	12 months	12 months	12 months
Net Sales	144052	169625	194838
Total Income	148872	175538	203461
Total Expenditure	118111	127477	135574
Other Income	4820	5913	8623
Operating Profit	30761	48061	67887
Interest	380	169	218
PBDT	30381	47892	67669
Depreciation	8143	9232	9756
Profit Before Tax	22238	38660	57913
Tax	6006	12532	14493
Profit After Tax	16232	26128	43420
Net Profit	16232	26128	43420
Equity Capital	832	833	834
Face Value (IN RS)	5	5	5
Reserves	182530	203909	241574
Calculated EPS	97.55	156.83	260.31
Diluted Eps After Extraordinary Items	97.58	157.03	260.46
Diluted Eps Before Extraordinary Items	97.58	157.03	260.46

Consolidated Standalone

CONSOLIDATED PROFIT / LOSS FOR DR. REDDY'S LABORATORIES LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Gross Sales	19047.5 Cr	21545.2 Cr	24669.7 Cr	28011.1 Cr
Sales	18447.2 Cr	20549.2 Cr	23498.6 Cr	27188.5 Cr
Processing Charges / Service Income	552 Cr	924.7 Cr	1128.4 Cr	776.8 Cr
Net Sales	19047.5 Cr	21545.2 Cr	24669.7 Cr	28011.1 Cr
Increase/Decrease in Stock	-790.5 Cr	-353.9 Cr	70.9 Cr	-680.5 Cr
Raw Material Consumed	6869.4 Cr	7796.1 Cr	7586.8 Cr	8889.2 Cr
Opening Raw Materials	1038.8 Cr	1214.8 Cr	1357.6 Cr	1186 Cr
Purchases Raw Materials	4471.8 Cr	4455.2 Cr	4048.2 Cr	5164.8 Cr
Closing Raw Materials	1214.8 Cr	1357.6 Cr	1186 Cr	1860.7 Cr
Other Direct Purchases / Brought in cost	2573.6 Cr	3483.7 Cr	3367 Cr	4399.1 Cr
Power & Fuel Cost	320.5 Cr	390.5 Cr	477.4 Cr	533.9 Cr
Electricity & Power	320.5 Cr	390.5 Cr	477.4 Cr	533.9 Cr
Employee Cost	3629.9 Cr	3885.8 Cr	4646.6 Cr	5030.1 Cr
Salaries, Wages & Bonus	3040.7 Cr	3214.9 Cr	3850.5 Cr	4125 Cr
Contributions to EPF & Pension Funds	259.9 Cr	294 Cr	362.2 Cr	397.4 Cr
Workmen and Staff Welfare Expenses	255.2 Cr	302.9 Cr	369.5 Cr	425.6 Cr
Other Manufacturing Expenses	1574.4 Cr	1602.2 Cr	1738.6 Cr	2087.2 Cr
Repairs and Maintenance	333.1 Cr	404.8 Cr	491.7 Cr	550.9 Cr
General and Administration Expenses	1251.8 Cr	1547.6 Cr	1497.5 Cr	1968.8 Cr
Rent , Rates & Taxes	143.1 Cr	153.7 Cr	157.1 Cr	187.3 Cr
Insurance	67.6 Cr	92.3 Cr	108.6 Cr	104.7 Cr
Professional and legal fees	509.5 Cr	658.5 Cr	610.4 Cr	854.5 Cr
Traveling and conveyance	99.5 Cr	138.6 Cr	253 Cr	297.3 Cr
Selling and Distribution Expenses	1567.7 Cr	1919.2 Cr	1989.4 Cr	2127.5 Cr
Advertisement & Sales Promotion	163.7 Cr	216.7 Cr	244.2 Cr	272.1 Cr
Sales Commissions & Incentives	45.3 Cr	182.4 Cr	49.9 Cr	36.3 Cr
Freight and Forwarding	587.1 Cr	540.6 Cr	604 Cr	546.8 Cr
Miscellaneous Expenses	754.4 Cr	990.3 Cr	313.5 Cr	121.8 Cr
Provision for doubtful debts	5.4 Cr	7.3 Cr	20.5 Cr	27.5 Cr
Loss on disposal of fixed assets(net)	4.2 Cr	0	121.1 Cr	0
Total Expenditure	15177.6 Cr	17777.8 Cr	18320.7 Cr	20078 Cr
Other Income	291.4 Cr	484.7 Cr	1055.5 Cr	894.3 Cr
Interest Received	82.6 Cr	96.5 Cr	118 Cr	227.8 Cr
Profit on sale of Fixed Assets	0	111.9 Cr	0	90 Cr
Provision Written Back	0	30 Lk	0	0
Foreign Exchange Gains	124.3 Cr	182.9 Cr	221 Cr	27.4 Cr
Operating Profit	4161.3 Cr	4252.1 Cr	7404.5 Cr	8827.4 Cr
Interest	97 Cr	95.8 Cr	142.8 Cr	171.1 Cr
Interest on Term Loan	9.4 Cr	21.8 Cr	142.8 Cr	145.5 Cr
PBDT	4064.3 Cr	4156.3 Cr	7261.7 Cr	8656.3 Cr
Depreciation	1228.8 Cr	1165.2 Cr	1250.2 Cr	1470 Cr
Profit Before Taxation & Exceptional Items	2835.5 Cr	2991.1 Cr	6011.5 Cr	7186.3 Cr
Profit Before Tax	2835.5 Cr	2991.1 Cr	6048.5 Cr	7201 Cr
Provision for Tax	931.9 Cr	878.9 Cr	1541.2 Cr	1623.1 Cr
Current Income Tax	817.2 Cr	1101.3 Cr	814.4 Cr	1945.9 Cr
Deferred Tax	114.7 Cr	-222.4 Cr	726.8 Cr	-322.8 Cr
Profit After Tax	1903.6 Cr	2112.2 Cr	4507.3 Cr	5577.9 Cr
Share of Associate	48 Cr	70.3 Cr	0	0
Consolidated Net Profit	1951.6 Cr	2182.5 Cr	4507.3 Cr	5577.9 Cr
Profit Balance B/F	12834.9 Cr	14239.5 Cr	16034.1 Cr	20022.8 Cr
Appropriations	14786.5 Cr	16422 Cr	20541.4 Cr	25600.7 Cr
Other Appropriation	547 Cr	387.9 Cr	518.6 Cr	602.7 Cr
Equity Dividend %	500	600	800	800
Earnings Per Share	117.28	131.16	270.55	334.41
Adjusted EPS	117.28	131.16	270.55	334.41

STANDALONE PROFIT / LOSS FOR DR. REDDY'S LABORATORIES LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Gross Sales	13349.1 Cr	14405.2 Cr	16962.5 Cr	19483.8 Cr
Sales	13236.4 Cr	13921.2 Cr	16338 Cr	19325.3 Cr
Processing Charges / Service Income	72 Cr	428.9 Cr	600.2 Cr	127.7 Cr
Net Sales	13349.1 Cr	14405.2 Cr	16962.5 Cr	19483.8 Cr
Increase/Decrease in Stock	-395.6 Cr	-389.6 Cr	129.5 Cr	-238.8 Cr
Raw Material Consumed	4518.6 Cr	5435.5 Cr	4940.7 Cr	5278.1 Cr
Opening Raw Materials	848 Cr	1011.3 Cr	1099.6 Cr	914.1 Cr
Purchases Raw Materials	3429.6 Cr	3466.7 Cr	2975.9 Cr	3916.9 Cr
Closing Raw Materials	1011.3 Cr	1099.6 Cr	914.1 Cr	1539.5 Cr
Other Direct Purchases / Brought in cost	1252.3 Cr	2057.1 Cr	1779.3 Cr	1986.6 Cr
Power & Fuel Cost	291.3 Cr	326.8 Cr	398.1 Cr	454.4 Cr
Electricity & Power	291.3 Cr	326.8 Cr	398.1 Cr	454.4 Cr
Employee Cost	2270.1 Cr	2434.6 Cr	2832.6 Cr	3085.7 Cr
Salaries, Wages & Bonus	1887.6 Cr	2002.6 Cr	2352.6 Cr	2487.4 Cr
Contributions to EPF & Pension Funds	129.5 Cr	146.6 Cr	176.9 Cr	213.8 Cr
Workmen and Staff Welfare Expenses	191.7 Cr	223.5 Cr	264.9 Cr	334.5 Cr
Other Manufacturing Expenses	1314.2 Cr	1398.7 Cr	1622.1 Cr	1976.3 Cr
Repairs and Maintenance	265 Cr	282.4 Cr	327.2 Cr	351 Cr
General and Administration Expenses	744.8 Cr	848 Cr	876 Cr	1114.5 Cr
Rent , Rates & Taxes	50.5 Cr	60 Cr	57.4 Cr	56.7 Cr
Insurance	45.6 Cr	67.6 Cr	74.8 Cr	67.5 Cr
Professional and legal fees	358.7 Cr	436.4 Cr	322.4 Cr	538.8 Cr
Traveling and conveyance	49.1 Cr	50.5 Cr	100.5 Cr	116 Cr
Selling and Distribution Expenses	1399.1 Cr	1685 Cr	1805.5 Cr	1754.2 Cr
Advertisement & Sales Promotion	37 Cr	82.6 Cr	69.8 Cr	668.2 Cr
Sales Commissions & Incentives	18.1 Cr	25.3 Cr	31.8 Cr	20.7 Cr
Freight and Forwarding	469.6 Cr	428.7 Cr	88.2 Cr	397.7 Cr
Miscellaneous Expenses	69.8 Cr	72.1 Cr	143.2 Cr	133 Cr
Provision for doubtful debts	6.9 Cr	6.5 Cr	16.1 Cr	17.7 Cr
Loss on disposal of fixed assets(net)	0	7.8 Cr	23.3 Cr	0
Total Expenditure	10212.3 Cr	11811.1 Cr	12747.7 Cr	13557.4 Cr
Other Income	801.1 Cr	482 Cr	591.3 Cr	862.3 Cr
Interest Received	122.3 Cr	166.9 Cr	130 Cr	304.6 Cr
Dividend Received	0	0	0	44.6 Cr
Profit on sale of Fixed Assets	471.1 Cr	0	0	77.1 Cr
Foreign Exchange Gains	123.7 Cr	220.9 Cr	328.1 Cr	14.2 Cr
Operating Profit	3937.9 Cr	3076.1 Cr	4806.1 Cr	6788.7 Cr
Interest	46.7 Cr	38 Cr	16.9 Cr	21.8 Cr
Interest on Term Loan	9.6 Cr	0	8.6 Cr	9.4 Cr
PBDT	3891.2 Cr	3038.1 Cr	4789.2 Cr	6766.9 Cr
Depreciation	835 Cr	814.3 Cr	923.2 Cr	975.6 Cr
Profit Before Taxation & Exceptional Items	3056.2 Cr	2223.8 Cr	3866 Cr	5791.3 Cr
Profit Before Tax	3056.2 Cr	2223.8 Cr	3866 Cr	5791.3 Cr
Provision for Tax	869.8 Cr	600.6 Cr	1253.2 Cr	1449.3 Cr
Current Income Tax	540.1 Cr	392.6 Cr	864.1 Cr	1361.8 Cr
Deferred Tax	329.7 Cr	208 Cr	389.1 Cr	87.5 Cr
Profit After Tax	2186.4 Cr	1623.2 Cr	2612.8 Cr	4342 Cr
Consolidated Net Profit	2186.4 Cr	1623.2 Cr	2612.8 Cr	4342 Cr
Profit Balance B/F	12497.9 Cr	14137.3 Cr	15403 Cr	17504.8 Cr
Appropriations	14684.3 Cr	15760.5 Cr	18015.8 Cr	21846.8 Cr
Other Appropriation	547 Cr	357.5 Cr	511 Cr	641.4 Cr
Equity Dividend %	500	600	800	800
Earnings Per Share	131.39	97.55	156.83	260.31
Adjusted EPS	131.39	97.55	156.83	260.31

Consolidated Standalone

CONSOLIDATED CASH FLOW FOR DR. REDDY'S LABORATORIES LIMITED

Year End	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Profit Before Tax	2883.5 Cr	3061.4 Cr	6048.5 Cr	7201 Cr
Adjustment	2087.2 Cr	1875.4 Cr	1695.9 Cr	1365.2 Cr
Changes In working Capital	-828.8 Cr	-1382.3 Cr	-785.5 Cr	-2018.2 Cr
Cash Flow after changes in Working Capital	4141.9 Cr	3554.5 Cr	6958.9 Cr	6548 Cr
Cash Flow from Operating Activities	3570.3 Cr	2810.8 Cr	5887.5 Cr	4543.3 Cr
Cash Flow from Investing Activities	-2266 Cr	-2638.7 Cr	-4137.3 Cr	-4028.3 Cr
Cash Flow from Financing Activitie	-29.8 Cr	-242.2 Cr	-2686.1 Cr	-376.3 Cr
Net Cash Inflow / Outflow	1274.5 Cr	-70.1 Cr	-935.9 Cr	138.7 Cr
Opening Cash & Cash Equivalents	196.2 Cr	1482 Cr	1485.2 Cr	577.9 Cr
Effect of Foreign Exchange Fluctuations	11.3 Cr	73.3 Cr	28.6 Cr	-5.9 Cr
Closing Cash & Cash Equivalent	1482 Cr	1485.2 Cr	577.9 Cr	710.7 Cr

STANDALONE CASH FLOW FOR DR. REDDY'S LABORATORIES LIMITED

Year End	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Profit Before Tax	3056.2 Cr	2223.8 Cr	3866 Cr	5791.3 Cr
Adjustment	273.3 Cr	583.1 Cr	1045.8 Cr	602 Cr
Changes In working Capital	632.7 Cr	-979.4 Cr	923.7 Cr	-1624.1 Cr
Cash Flow after changes in Working Capital	3962.2 Cr	1827.5 Cr	5835.5 Cr	4769.2 Cr
Cash Flow from Operating Activities	3514.2 Cr	1338.7 Cr	5052.8 Cr	3449.7 Cr
Cash Flow from Investing Activities	-1458 Cr	-2038 Cr	-3447.6 Cr	-3430.3 Cr
Cash Flow from Financing Activitie	-794.3 Cr	505.5 Cr	-2696.9 Cr	68.1 Cr
Net Cash Inflow / Outflow	1261.9 Cr	-193.8 Cr	-1091.7 Cr	87.5 Cr
Opening Cash & Cash Equivalents	39.1 Cr	1305.4 Cr	1159.5 Cr	112.3 Cr
Effect of Foreign Exchange Fluctuations	4.4 Cr	47.9 Cr	44.5 Cr	1.6 Cr
Closing Cash & Cash Equivalent	1305.4 Cr	1159.5 Cr	112.3 Cr	201.4 Cr

Consolidated Standalone

CONSOLIDATED BALANCE SHEET FOR DR. REDDY'S LABORATORIES LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Share Capital	83.2 Cr	83.2 Cr	83.3 Cr	83.4 Cr
Equity - Authorised	120 Cr	120 Cr	120 Cr	145 Cr
Equity - Issued	83.2 Cr	83.2 Cr	83.3 Cr	83.4 Cr
Equity Paid Up	83.2 Cr	83.2 Cr	83.3 Cr	83.4 Cr
Face Value	5	5	5	5
Total Reserves	17431.9 Cr	18985.9 Cr	23057.1 Cr	28040.1 Cr
Securities Premium	630.8 Cr	670.1 Cr	710.9 Cr	818.6 Cr
Capital Reserves	26.7 Cr	26.7 Cr	26.7 Cr	26.7 Cr
Profit & Loss Account Balance	14239.5 Cr	16034.1 Cr	20022.8 Cr	24998 Cr
General Reserves	2037.4 Cr	2037.4 Cr	2037.4 Cr	2037.4 Cr
Reserve excluding Revaluation Reserve	17431.9 Cr	18985.9 Cr	23057.1 Cr	28040.1 Cr
Shareholder's Funds	17641.7 Cr	19212.4 Cr	23286.1 Cr	28254.8 Cr
Secured Loans	249.9 Cr	0	127.8 Cr	219 Cr
Unsecured Loans	380 Cr	380 Cr	0	380 Cr
Loans - Banks	0	0	0	380 Cr
Deferred Tax Assets / Liabilities	-1039.7 Cr	-1275.6 Cr	-629.2 Cr	-973.7 Cr
Deferred Tax Assets	1343 Cr	1629.6 Cr	945 Cr	1445.1 Cr
Deferred Tax Liability	303.3 Cr	354 Cr	315.8 Cr	471.4 Cr
Other Long Term Liabilities	161.7 Cr	361.5 Cr	203.2 Cr	314 Cr
Long Term Provisions	50.8 Cr	25.8 Cr	19.9 Cr	23.9 Cr
Total Non-Current Liabilities	-197.3 Cr	-508.3 Cr	-278.3 Cr	-36.8 Cr
Trade Payables	1810.9 Cr	2266.2 Cr	2268.4 Cr	2614.4 Cr
Sundry Creditors	1810.9 Cr	2266.2 Cr	2268.4 Cr	2614.4 Cr
Other Current Liabilities	3338.1 Cr	3660.6 Cr	4697.9 Cr	4775.2 Cr
Advances received from customers	98.1 Cr	134.1 Cr	116.9 Cr	106.1 Cr
Interest Accrued But Not Due	9.4 Cr	12.8 Cr	13 Cr	6.2 Cr
Current maturity of Debentures & Bonds	0	0	380 Cr	0
Current maturity - Others	86.4 Cr	0	100.4 Cr	130.7 Cr
Short Term Borrowings	2314.5 Cr	2708.2 Cr	739 Cr	1272.3 Cr
Short Term Provisions	640.3 Cr	1130.8 Cr	866.8 Cr	926.1 Cr
Provision for Tax	138.8 Cr	544.2 Cr	214.3 Cr	234.1 Cr
Provision for post retirement benefits	3.3 Cr	2.3 Cr	0	0
Total Current Liabilities	8103.8 Cr	9765.8 Cr	8572.1 Cr	9588 Cr
Total Liabilities	25548.2 Cr	28469.9 Cr	31579.9 Cr	37806 Cr
Gross Block	21886.7 Cr	23096.3 Cr	25567.1 Cr	28062.2 Cr
Less: Accumulated Depreciation	13632.1 Cr	14679.1 Cr	16276.9 Cr	17636.1 Cr
Less: Impairment of Assets	48.9 Cr	295.7 Cr	71.1 Cr	50 Lk
Net Block	8205.7 Cr	8121.5 Cr	9219.1 Cr	10425.6 Cr
Capital Work in Progress	953.9 Cr	1279.6 Cr	975.2 Cr	1351 Cr
Non Current Investments	833.3 Cr	592.9 Cr	645.6 Cr	542.2 Cr
Long Term Investment	833.3 Cr	592.9 Cr	645.6 Cr	542.2 Cr
Quoted	453.2 Cr	119.8 Cr	35.1 Cr	38.4 Cr
Unquoted	380.1 Cr	473.1 Cr	610.5 Cr	503.8 Cr
Long Term Loans & Advances	376.9 Cr	451.7 Cr	355.9 Cr	541.8 Cr
Other Non Current Assets	16.9 Cr	222.4 Cr	13.1 Cr	88.5 Cr
Total Non-Current Assets	10997.9 Cr	10681.9 Cr	11263.8 Cr	13017.4 Cr
Currents Investments	1974.4 Cr	2022.9 Cr	4340.2 Cr	4388.3 Cr
Unquoted	380.1 Cr	473.1 Cr	610.5 Cr	503.8 Cr
Inventories	4541.2 Cr	5088.4 Cr	4867 Cr	6355.2 Cr
Raw Materials	1214.8 Cr	1357.6 Cr	1186 Cr	1860.7 Cr
Work-in Progress	1000.9 Cr	1288.6 Cr	1169.8 Cr	1422.2 Cr
Finished Goods	1373.2 Cr	1386.5 Cr	1361.7 Cr	1986.9 Cr
Stores and Spare	328.7 Cr	380 Cr	392.7 Cr	504.9 Cr
Sundry Debtors	4964.1 Cr	6676.4 Cr	7248.5 Cr	8029.8 Cr
Debtors more than Six months	0	77.6 Cr	280.5 Cr	469 Cr
Debtors Others	5093.7 Cr	6718.2 Cr	7093.8 Cr	7705.9 Cr
Cash and Bank	1482.9 Cr	2419.2 Cr	1730.2 Cr	1727.7 Cr
Cash in hand	10 Lk	10 Lk	10 Lk	10 Lk
Balances at Bank	1482.8 Cr	2419.1 Cr	1730.1 Cr	1727.6 Cr
Other Current Assets	865 Cr	737 Cr	1203.5 Cr	1060.1 Cr
Prepaid Expenses	114.1 Cr	113.8 Cr	145.2 Cr	194.7 Cr
Short Term Loans and Advances	722.7 Cr	844.1 Cr	926.7 Cr	3227.5 Cr
Advances recoverable in cash or in kind	15.7 Cr	14.5 Cr	27.7 Cr	13 Cr
Total Current Assets	14550.3 Cr	17788 Cr	20316.1 Cr	24788.6 Cr
Net Current Assets (Including Current Investments)	6446.5 Cr	8022.2 Cr	11744 Cr	15200.6 Cr
Total Assets	25548.2 Cr	28469.9 Cr	31579.9 Cr	37806 Cr
Contingent Liabilities	174.3 Cr	107.6 Cr	107.6 Cr	107.2 Cr
Total Debt	3030.8 Cr	3088.2 Cr	1347.2 Cr	2002 Cr
Book Value	1052.59	0	1388.98	0
Adjusted Book Value	1052.59	1145.98	1388.98	1686.06

STANDALONE BALANCE SHEET FOR DR. REDDY'S LABORATORIES LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Share Capital	83.2 Cr	83.2 Cr	83.3 Cr	83.4 Cr
Equity - Authorised	120 Cr	120 Cr	120 Cr	145 Cr
Equity - Issued	83.2 Cr	83.2 Cr	83.3 Cr	83.4 Cr
Equity Paid Up	83.2 Cr	83.2 Cr	83.3 Cr	83.4 Cr
Face Value	5	5	5	5
Total Reserves	16773.9 Cr	18109.7 Cr	20245.2 Cr	24026.1 Cr
Securities Premium	630.1 Cr	669.4 Cr	710.2 Cr	817.9 Cr
Capital Reserves	26.7 Cr	26.7 Cr	26.7 Cr	26.7 Cr
Profit & Loss Account Balance	14137.3 Cr	15403 Cr	17504.8 Cr	21205.4 Cr
General Reserves	2030.2 Cr	2030.2 Cr	2030.2 Cr	2030.2 Cr
Reserve excluding Revaluation Reserve	16773.9 Cr	18109.7 Cr	20245.2 Cr	24026.1 Cr
Shareholder's Funds	16983.7 Cr	18336.2 Cr	20474.2 Cr	24240.8 Cr
Secured Loans	17.7 Cr	0	28.6 Cr	49.5 Cr
Deferred Tax Assets / Liabilities	-254.8 Cr	-19.4 Cr	339.2 Cr	416.1 Cr
Deferred Tax Assets	575.6 Cr	441.6 Cr	69.6 Cr	95.1 Cr
Deferred Tax Liability	320.8 Cr	422.2 Cr	408.8 Cr	511.2 Cr
Other Long Term Liabilities	42.8 Cr	103.9 Cr	85.2 Cr	105.5 Cr
Long Term Provisions	25.1 Cr	10.4 Cr	7.9 Cr	9.3 Cr
Total Non-Current Liabilities	-169.2 Cr	94.9 Cr	460.9 Cr	580.4 Cr
Trade Payables	1336.4 Cr	1666.2 Cr	1764.5 Cr	2044.8 Cr
Sundry Creditors	1336.4 Cr	1666.2 Cr	1643 Cr	1970.2 Cr
Due to Subsidiaries- Trade Payables	0	0	121.5 Cr	74.6 Cr
Other Current Liabilities	1744.3 Cr	1885.6 Cr	2369.4 Cr	2388 Cr
Advances received from customers	29.6 Cr	58.8 Cr	39.9 Cr	23.2 Cr
Interest Accrued But Not Due	0	40 Lk	0	2.8 Cr
Current maturity - Others	15.9 Cr	0	21.6 Cr	33.4 Cr
Short Term Borrowings	1180.9 Cr	2171.1 Cr	60 Lk	710 Cr
Short Term Provisions	298.7 Cr	322.2 Cr	305.2 Cr	395.3 Cr
Provision for Tax	0	0	0	67 Cr
Provision for post retirement benefits	1.6 Cr	1.5 Cr	0	0
Total Current Liabilities	4560.3 Cr	6045.1 Cr	4439.7 Cr	5538.1 Cr
Total Liabilities	21374.8 Cr	24476.2 Cr	25374.8 Cr	30359.3 Cr
Gross Block	12345 Cr	13349.1 Cr	15074.9 Cr	16297.2 Cr
Less: Accumulated Depreciation	6489.7 Cr	7198.6 Cr	7863.1 Cr	8710.9 Cr
Less: Impairment of Assets	11 Cr	0	5.1 Cr	-2.8 Cr
Net Block	5844.3 Cr	6150.5 Cr	7206.7 Cr	7589.1 Cr
Capital Work in Progress	877.1 Cr	1186.4 Cr	899.1 Cr	1171.9 Cr
Non Current Investments	3392.2 Cr	3018.7 Cr	3248.6 Cr	3216.3 Cr
Long Term Investment	3392.2 Cr	3018.7 Cr	3248.6 Cr	3216.3 Cr
Quoted	90 Lk	21.2 Cr	8.3 Cr	13.6 Cr
Unquoted	3453.5 Cr	3060.2 Cr	3303 Cr	3294.2 Cr
Long Term Loans & Advances	293.2 Cr	409.8 Cr	324.6 Cr	507.2 Cr
Other Non Current Assets	10 Lk	207.7 Cr	0	33.4 Cr
Total Non-Current Assets	10430.6 Cr	10987 Cr	11692.9 Cr	12557 Cr
Currents Investments	1597.2 Cr	1918 Cr	4191.4 Cr	4104.3 Cr
Unquoted	3453.5 Cr	3060.2 Cr	3303 Cr	3294.2 Cr
Inventories	2819.7 Cr	3347.8 Cr	3043 Cr	4018.9 Cr
Raw Materials	1011.3 Cr	1099.6 Cr	914.1 Cr	1539.5 Cr
Work-in Progress	888.6 Cr	1110 Cr	1025 Cr	1207.1 Cr
Finished Goods	462.1 Cr	517.7 Cr	514.5 Cr	526.3 Cr
Packing Materials	301.9 Cr	346.5 Cr	359.6 Cr	465.6 Cr
Sundry Debtors	4080 Cr	4945.4 Cr	4288.9 Cr	4623.9 Cr
Debtors more than Six months	0	43 Cr	333 Cr	334.3 Cr
Debtors Others	4124 Cr	4944.6 Cr	3998.6 Cr	4344.4 Cr
Cash and Bank	1306.3 Cr	2030.5 Cr	645.8 Cr	1216.9 Cr
Balances at Bank	1306.3 Cr	2030.5 Cr	645.8 Cr	1216.9 Cr
Other Current Assets	480.4 Cr	465.6 Cr	666.2 Cr	788 Cr
Interest accrued on Investments	11.4 Cr	20.9 Cr	47.3 Cr	132.8 Cr
Prepaid Expenses	73.8 Cr	70.6 Cr	95.6 Cr	105.3 Cr
Short Term Loans and Advances	660.6 Cr	781.9 Cr	846.6 Cr	3050.3 Cr
Advances recoverable in cash or in kind	68.9 Cr	60.5 Cr	39.8 Cr	38.8 Cr
Due From Subsidiaries	11.5 Cr	12.6 Cr	24.5 Cr	37.4 Cr
Total Current Assets	10944.2 Cr	13489.2 Cr	13681.9 Cr	17802.3 Cr
Net Current Assets (Including Current Investments)	6383.9 Cr	7444.1 Cr	9242.2 Cr	12264.2 Cr
Total Assets	21374.8 Cr	24476.2 Cr	25374.8 Cr	30359.3 Cr
Contingent Liabilities	168.1 Cr	107.6 Cr	107.6 Cr	107.2 Cr
Total Debt	1214.5 Cr	2171.1 Cr	50.8 Cr	792.9 Cr
Book Value	1013.05	0	1220.2	0
Adjusted Book Value	1013.05	1093.32	1220.2	1445.41

Consolidated Standalone

FINANCIAL RATIOS (CONSOLIDATED) FOR DR. REDDY'S LABORATORIES LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Operational & Financial Ratios
Earnings Per Share (Rs)	117.28	131.16	270.55	334.41
CEPS(Rs)	188.25	196.96	345.59	422.54
DPS(Rs)	25	30	40	40
Book NAV/Share(Rs)	1052.59	1145.98	1388.98	1686.06
Tax Rate(%)	32.87	29.38	25.48	22.54
Margin Ratios
Core EBITDA Margin(%)	20.32	17.49	25.74	28.32
EBIT Margin(%)	15.4	14.33	25.1	26.32
Pre Tax Margin(%)	14.89	13.88	24.52	25.71
PAT Margin (%)	9.99	9.8	18.27	19.91
Cash Profit Margin (%)	16.45	15.21	23.34	25.16
Performance Ratios
ROA(%)	8.01	7.82	15.01	16.08
ROE(%)	11.53	11.55	21.36	21.76
ROCE(%)	15.24	14.48	26.22	26.86
Asset Turnover(x)	0.8	0.8	0.82	0.81
Sales/Fixed Asset(x)	0.92	0.96	1.01	1.04
Working Capital/Sales(x)	2.95	2.69	2.1	1.84
Efficiency Ratios
Fixed Capital/Sales(x)	1.08	1.04	0.99	0.96
Receivable days	95.74	98.6	103.01	99.54
Inventory Days	77.11	81.57	73.65	73.12
Payable days	40.73	99.98	108.07	108.56
Valuation Parameters
PER(x)	38.5	32.83	17.08	18.41
PCE(x)	23.99	21.86	13.37	14.57
Price/Book(x)	4.29	3.76	3.33	3.65
Yield(%)	0.55	0.7	0.87	0.65
EV/Net Sales(x)	4.03	3.36	3.11	3.68
EV/Core EBITDA(x)	18.43	17.01	10.35	11.66
EV/EBIT(x)	26.15	23.43	12.37	13.96
EV/CE(x)	3	2.54	2.43	3.4
M Cap / Sales	3.94	3.33	3.12	3.67
Growth Ratio
Net Sales Growth(%)	8.74	13.11	14.5	13.54
Core EBITDA Growth(%)	34.63	2.18	74.14	19.22
EBIT Growth(%)	52.11	5.27	96.1	19.07
PAT Growth(%)	-3.37	10.96	106.52	23.75
EPS Growth(%)	-3.79	11.83	106.27	23.6
Financial Stability Ratios
Total Debt/Equity(x)	0.17	0.16	0.06	0.07
Current Ratio(x)	1.8	1.82	2.37	2.59
Quick Ratio(x)	1.24	1.3	1.8	1.92
Interest Cover(x)	30.23	32.22	43.36	43.09
Total Debt/Mcap(x)	0.04	0.04	0.02	0.02

FINANCIAL RATIOS (STANDALONE) FOR DR. REDDY'S LABORATORIES LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Operational & Financial Ratios
Earnings Per Share (Rs)	131.39	97.55	156.83	260.31
CEPS(Rs)	181.58	146.48	212.25	318.8
DPS(Rs)	25	30	40	40
Book NAV/Share(Rs)	1013.05	1093.32	1220.2	1445.41
Tax Rate(%)	28.46	27.01	32.42	25.03
Margin Ratios
Core EBITDA Margin(%)	23.5	18.01	24.85	30.42
EBIT Margin(%)	23.24	15.7	22.89	29.84
Pre Tax Margin(%)	22.89	15.44	22.79	29.72
PAT Margin (%)	16.38	11.27	15.4	22.29
Cash Profit Margin (%)	22.63	16.92	20.85	27.29
Performance Ratios
ROA(%)	10.87	7.08	10.48	15.58
ROE(%)	13.69	9.26	13.57	19.54
ROCE(%)	17.81	11.7	18.91	25.52
Asset Turnover(x)	0.66	0.63	0.68	0.7
Sales/Fixed Asset(x)	1.18	1.12	1.19	1.24
Working Capital/Sales(x)	2.09	1.94	1.84	1.59
Efficiency Ratios
Fixed Capital/Sales(x)	0.85	0.89	0.84	0.81
Receivable days	119.2	114.34	99.35	83.48
Inventory Days	68.49	78.14	68.76	66.15
Payable days	42.24	108.6	115.51	130.85
Valuation Parameters
PER(x)	34.37	44.14	29.47	23.65
PCE(x)	24.87	29.39	21.77	19.31
Price/Book(x)	4.46	3.94	3.79	4.26
Yield(%)	0.55	0.7	0.87	0.65
EV/Net Sales(x)	5.62	4.98	4.5	5.25
EV/Core EBITDA(x)	19.06	23.34	15.9	15.06
EV/EBIT(x)	24.19	31.74	19.68	17.59
EV/CE(x)	3.51	2.93	3.01	4.08
M Cap / Sales	5.63	4.97	4.54	5.27
Growth Ratio
Net Sales Growth(%)	12.65	7.91	17.75	14.86
Core EBITDA Growth(%)	9	-21.88	56.24	41.25
EBIT Growth(%)	9.89	-27.11	71.67	49.71
PAT Growth(%)	-25.57	-25.76	60.97	66.18
EPS Growth(%)	-25.66	-25.76	60.77	65.98
Financial Stability Ratios
Total Debt/Equity(x)	0.07	0.12	0	0.03
Current Ratio(x)	2.4	2.23	3.08	3.21
Quick Ratio(x)	1.78	1.68	2.4	2.49
Interest Cover(x)	66.44	59.52	229.76	266.66
Total Debt/Mcap(x)	0.02	0.03	0	0.01

SHARE HOLDING PATTERN FOR DR. REDDY'S LABORATORIES LIMITED

Date	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoters %	26.71	26.71	26.70	26.70	26.69	26.66	26.65	26.65	26.65	26.64
FII %	25.87	26.26	27.29	27.25	26.99	28.19	28.62	29.13	27.68	27.53
DII %	0.24	0.23	0.19	0.17	0.11	0.19	0.25	0.26	0.15	0.10
Public %	11.87	12.28	12.10	11.70	11.78	10.09	10.75	10.55	10.36	10.13

PEER COMPARISON FOR DR. REDDY'S LABORATORIES LIMITED

No.	Name
1	AMBALAL SARABHAI ENTERPRISES LTD
2	Cipla Limited
3	Dr. Reddy's Laboratories Limited
4	Procter & Gamble Health Limited
5	J.K.PHARMACHEM LTD
6	Lupin Limited
7	Lyka Labs Limited
8	MESCO PHARMACEUTICALS LTD
9	Morepen Laboratories Limited
10	Piramal Enterprises Limited
11	Torrent Pharmaceuticals Limited
12	Abbott India Limited
13	GlaxoSmithKline Pharmaceuticals Limited
14	Sanofi India Limited
15	Pfizer Limited
16	Bliss GVS Pharma Limited
17	Alembic Limited
18	Unichem Laboratories Limited
19	AstraZeneca Pharma India Limited
20	GUJARAT THEMIS BIOSYN LTD
21	JB Chemicals & Pharmaceuticals Limited
22	TTK Healthcare Limited
23	Jagsonpal Pharmaceuticals Limited
24	Gufic Biosciences Limited
25	Sequent Scientific Limited
26	Albert David Limited
27	IOL Chemicals and Pharmaceuticals Limited
28	Wanbury Limited
29	Kopran Limited
30	Aarti Drugs Limited
31	Orchid Pharma Limited
32	Biofil Chemicals & Pharmaceuticals Limited
33	Marksans Pharma Limited
34	IPCA Laboratories Limited
35	Kilitch Drugs (India) Limited
36	Krebs Biochemicals and Industries Limited
37	Neuland Laboratories Limited
38	Ind-Swift Limited
39	Hester Biosciences Limited
40	Parenteral Drugs (India) Limited
41	Sun Pharmaceutical Industries Limited
42	Hikal Limited
43	Caplin Point Laboratories Limited
44	Aurobindo Pharma Limited
45	Natco Pharma Limited
46	Bal Pharma Limited
47	BDH INDUSTRIES LTD
48	Venus Remedies Limited
49	Jubilant Pharmova Limited
50	Themis Medicare Limited

CORPORATE ACTIONS FOR DR. REDDY'S

Exchange Date	Purpose	Book Closure Dates
BSE 23-Sep-2024	Board Meeting - Quarterly Results	05-Nov-2024
BSE 29-Jul-2024	Split or Consolidation - Stock Split Inter alia, approved:- 1. Sub-division/ split Sub-division/ split of each equity share of the Company having face value of Rs.5/- (Rupees five only) each, fully paid-up, into 5 (Five) equity shares having face value of Re.1/- (Rupee one only) each, fully paid-up, by alteration of the Capital Clause of the Memorandum of Association of the Company. Further, each American Depositary Share...
BSE 23-Jul-2024	Split or Consolidation - Quarterly Results & Stock Split
BSE 21-Jun-2024	Board Meeting - Quarterly Results	27-Jul-2024
BSE 07-May-2024	Book Closure - Rs.40.0000 per share(800%)Final Dividend & A.G.M.	17-Jul-2024 19-Jul-2024
BSE 07-May-2024	AGM - Rs.40.0000 per share(800%)Final Dividend & A.G.M.	19-Jul-2024 19-Jul-2024
BSE 07-May-2024	Dividend - Rs.40.0000 per share(800%)Final Dividend
BSE 22-Mar-2024	Board Meeting - Audited Results & Final Dividend	07-May-2024
BSE 29-Dec-2023	SAST - Acquisition of securities by a wholly-owned step-down subsidiary company
BSE 21-Dec-2023	Board Meeting - Quarterly Results	30-Jan-2024
BSE 13-Nov-2023	SAST - Acquisition of securities of O2 Renewable Energy IX Private Limited
BSE 22-Sep-2023	Board Meeting - Quarterly Results	27-Oct-2023
BSE 11-Jul-2023	Dividend - Rs.40.0000 per share(800%)Final Dividend
BSE 21-Jun-2023	Board Meeting - Quarterly Results	26-Jul-2023
BSE 10-May-2023	Book Closure - Rs.40.0000 per share(800%)Final Dividend & A.G.M.	12-Jul-2023 14-Jul-2023
BSE 10-May-2023	AGM - Rs.40.0000 per share(800%)Final Dividend & A.G.M.	27-Jul-2023 14-Jul-2023
BSE 23-Mar-2023	Board Meeting - Audited Results & Final Dividend	10-May-2023
BSE 27-Dec-2022	Board Meeting - Quarterly Results	25-Jan-2023
BSE 28-Sep-2022	Board Meeting - Quarterly Results	28-Oct-2022
BSE 29-Jun-2022	Board Meeting - Quarterly Results	28-Jul-2022
BSE 20-May-2022	Book Closure - Rs.30.0000 per share(600%)Final Dividend & A.G.M.	13-Jul-2022 15-Jul-2022
BSE 20-May-2022	AGM - Rs.30.0000 per share(600%)Final Dividend & A.G.M.	29-Jul-2022 15-Jul-2022
BSE 19-May-2022	Dividend - Rs.30.0000 per share(600%)Final Dividend
BSE 29-Mar-2022	Board Meeting - Final Dividend & Audited Results	19-May-2022
BSE 28-Dec-2021	Board Meeting - Quarterly Results	28-Jan-2022
BSE 24-Sep-2021	Board Meeting - Quarterly Results	29-Oct-2021

CORPORATE ANNOUNCEMENTS FOR DR. REDDY'S

Exchange Date	Category File	Description
BSE 29-Oct-2024	General Announcements FILE	Update On Stock Split Update on Stock Split
BSE 28-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Press Release / Media Release Press Release
BSE 21-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Earnings Call notification for Q2 FY 2025
BSE 18-Oct-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Loss of Share Certificate(s)
BSE 14-Oct-2024	General Announcements FILE	Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015
BSE 11-Oct-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Issue of Letter of confirmation in lieu of share certificate(s) reported lost/ misplaced
BSE 10-Oct-2024	General Announcements FILE	Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015
BSE 08-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Press Release / Media Release Press Release
BSE 07-Oct-2024	General Announcements FILE	Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018
BSE 05-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Acquisition Incorporation of step down wholly-owned subsidiary
BSE 04-Oct-2024	Intimation FILE	Fixation Of Record Date For Sub-Division / Split Of The Equity Shares Of The Company Pursuant To Regulation 42 Of The SEBI (LODR) Regulations 2015 Fixation of Record date for Sub-division / split of the Equity shares of the Company pursuant to Regulation 42 of the SEBI (LODR) Regulations 2015
BSE 02-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Press Release / Media Release Press Release
BSE 01-Oct-2024	General Announcements FILE	Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015
BSE 30-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Updates on Acquisition Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015
BSE 27-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Updates on Acquisition Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015
BSE 26-Sep-2024	General Announcements FILE	Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015
BSE 25-Sep-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Loss of Share Certificate(s)
BSE 22-Sep-2024	Intimation FILE	Closure of Trading Window Intimation regarding closure of Trading window
BSE 22-Sep-2024	Intimation FILE	Board Meeting Intimation for Approval Of Unaudited Financial Results Of The Company For The Quarter And Half Ending On September 30 2024 DR.REDDYs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2024 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ending on September 30 2024
BSE 21-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS Allotment of shares on exercise of Employee Stock Options
BSE 20-Sep-2024	General Announcements FILE	Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015
BSE 17-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Newspaper Publication Copy of Newspaper Publication
BSE 16-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Schedule of Analyst / Institutional Investor Meeting
BSE 12-Sep-2024	Outcome FILE	Shareholder Meeting / Postal Ballot-Scrutinizer"s Report Scrutinizers Report
BSE 12-Sep-2024	Outcome FILE	Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot Results of voting through Postal Ballot
BSE 10-Sep-2024	General Announcements FILE	Intimation Under Regulation 30(11) Of SEBI (LODR) Regulations 2015 Intimation under Regulation 30(11) of SEBI (LODR) Regulations 2015
BSE 06-Sep-2024	General Announcements FILE	Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015
BSE 05-Sep-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Issue of letter of confirmation in lieu of share certificate(s) reported to be lost/misplaced
BSE 31-Aug-2024	General Announcements FILE	Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015
BSE 30-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Schedule of Analyst / Institutional Investor Meeting

INSIDER TRADING FOR DR. REDDY'S

Exchange Dates	Activity	Qty & Price (%)	Person / Organisation
BSE 20-Sep-2024 20-Sep-2024	Buy ESOP	1,412 @ 0.00 (0.00 %)	Anjum Swaroop
BSE 23-Sep-2024 23-Sep-2024	Sell Others	1,700 @ 0.00 (0.00 %)	C Swaminathan
BSE 20-Sep-2024 20-Sep-2024	Buy ESOP	1,594 @ 0.00 (0.00 %)	Vincent Colicchio
BSE 29-Aug-2024 29-Aug-2024	Buy ESOP	474 @ 0.00 (0.00 %)	Jeff Jorgenson
BSE 29-Aug-2024 29-Aug-2024	Buy ESOP	145 @ 0.00 (0.00 %)	Juan Carlos Alvarez
BSE 29-Aug-2024 29-Aug-2024	Buy ESOP	704 @ 0.00 (0.00 %)	Subba Inta
BSE 29-Aug-2024 29-Aug-2024	Buy ESOP	1,250 @ 0.00 (0.00 %)	C Swaminathan
BSE 29-Aug-2024 29-Aug-2024	Buy ESOP	215 @ 0.00 (0.00 %)	Sanjay Choubey
BSE 29-Aug-2024 29-Aug-2024	Buy ESOP	150 @ 0.00 (0.00 %)	Bryan Dixon
BSE 29-Aug-2024 29-Aug-2024	Buy ESOP	594 @ 0.00 (0.00 %)	Tricia Wetzel
BSE 29-Aug-2024 29-Aug-2024	Buy ESOP	814 @ 0.00 (0.00 %)	Milan Kalawadia
BSE 14-Jun-2024 14-Jun-2024	Buy ESOP	625 @ 0.00 (0.00 %)	C Swaminathan
BSE 14-Jun-2024 14-Jun-2024	Buy ESOP	136 @ 0.00 (0.00 %)	Sonal Shah
BSE 14-Mar-2024 14-Mar-2024	Buy ESOP	80 @ 0.00 (0.00 %)	Keerthi Kandlikar
BSE 14-Mar-2024 14-Mar-2024	Buy ESOP	1,550 @ 0.00 (0.00 %)	Tricia N Wetzel
BSE 14-Mar-2024 14-Mar-2024	Buy ESOP	503 @ 0.00 (0.00 %)	Jaya Lakshmi Ayyagari
BSE 22-Feb-2024 22-Feb-2024	Buy ESOP	160 @ 0.00 (0.00 %)	Uragasainareddy Medapati
BSE 22-Feb-2024 22-Feb-2024	Buy ESOP	175 @ 0.00 (0.00 %)	John Roosenberg II
BSE 22-Feb-2024 22-Feb-2024	Buy ESOP	250 @ 0.00 (0.00 %)	Mayank Nagar
BSE 08-Feb-2024 08-Feb-2024	Sell Market	3,744 @ 0.00 (0.00 %)	Anjum Swaroop
BSE 09-Dec-2023 09-Dec-2023	Buy ESOP	230 @ 0.00 (0.00 %)	Shobha Chagam
BSE 09-Dec-2023 09-Dec-2023	Buy ESOP	8,215 @ 0.00 (0.01 %)	Marc Kikuchi
BSE 15-Sep-2023 15-Sep-2023	Sell Market	2,000 @ 0.00 (0.00 %)	C Swaminathan
BSE 05-Sep-2023 05-Sep-2023	Buy ESOP	8,304 @ 0.00 (0.00 %)	Vanessa Brill
BSE 24-Aug-2023 24-Aug-2023	Buy ESOP	875 @ 0.00 (0.00 %)	C Swaminathan
BSE 24-Aug-2023 24-Aug-2023	Buy ESOP	3,744 @ 0.00 (0.00 %)	Anjum Swaroop
BSE 24-Aug-2023 24-Aug-2023	Buy ESOP	215 @ 0.00 (0.00 %)	Sanjay Choubey
BSE 24-Aug-2023 24-Aug-2023	Buy ESOP	1,175 @ 0.00 (0.00 %)	Tricia Wetzel
BSE 31-Jul-2023 01-Aug-2023	Sell ESOP	197,165 @ 0.00 (0.12 %)	EREZ ISRAELI
BSE 03-Aug-2023 03-Aug-2023	Buy ESOP	197,165 @ 0.00 (0.12 %)	EREZ ISRAELI

BULK BLOCK DEALS FOR DR. REDDY'S LABORATORIES LIMITED

Exchange Dates	Activity	Qty & Price (%)	Person / Organisation
BSE 26-Mar-2024	Buy BLOCK	260,000 @ 6184.85	BOFA SECURITIES EUROPE SA
BSE 26-Mar-2024	Sell BLOCK	260,000 @ 6184.85	BOFA SECURITIES EUROPE SA
BSE 18-Jan-2024	Sell BLOCK	31,907 @ 5645.45	JUPITER SOUTH ASIA INVESTMENT COMPANY LIMITED
BSE 18-Jan-2024	Buy BLOCK	31,907 @ 5645.45	THE JUPITER GLOBAL FUND-JUPITER INDIA SELECT
BSE 26-Oct-2023	Sell BLOCK	428 @ 5355.20	AIA INVESTMENT TRUST AIA SINGAPORE PARTCIPATING FUND HERITAGE SGD
BSE 26-Oct-2023	Sell BLOCK	836 @ 5355.20	AIA INVESTMENT TRUST AIA SINGAPORE PARTICIPATING FUND HERITAGE USD
BSE 26-Oct-2023	Sell BLOCK	1,551 @ 5355.20	AIA INVESTMENT TRUST AIA SINGAPORE PARTICIPATING FUND USD
BSE 26-Oct-2023	Sell BLOCK	17,456 @ 5355.20	AIA INVESTMENT TRUST-AIA SINGAPORE PARTICIPATING FUND SGD
BSE 26-Oct-2023	Buy BLOCK	20,271 @ 5355.20	AIA VCC - AIA ASIAN EQUITY FUND
BSE 19-Oct-2023	Sell BLOCK	35,442 @ 5656.20	AIA INVESTMENT TRUST - AIA SINGAPORE PARTICIPATING FUND SGD
BSE 19-Oct-2023	Sell BLOCK	870 @ 5656.20	AIA INVESTMENT TRUST AIA SINGAPORE PARTCIPATING FUND HERITAGE SGD
BSE 19-Oct-2023	Sell BLOCK	1,696 @ 5656.20	AIA INVESTMENT TRUST AIA SINGAPORE PARTICIPATING FUND HERITAGE USD
BSE 19-Oct-2023	Sell BLOCK	3,149 @ 5656.20	AIA INVESTMENT TRUST AIA SINGAPORE PARTICIPATING FUND USD
BSE 19-Oct-2023	Buy BLOCK	41,157 @ 5656.20	AIA VCC - AIA ASIAN EQUITY FUND
BSE 11-Oct-2023	Sell BLOCK	5,326 @ 5563.00	AIA INTERNATIONAL LIMITED
BSE 11-Oct-2023	Sell BLOCK	9,894 @ 5563.00	AIA INTERNATIONAL LIMITED
BSE 11-Oct-2023	Sell BLOCK	19,410 @ 5563.00	AIA INTERNATIONAL LIMITED
BSE 11-Oct-2023	Sell BLOCK	41,013 @ 5563.00	AIA INTERNATIONAL LIMITED
BSE 11-Oct-2023	Sell BLOCK	433 @ 5563.00	AIA INVESTMENT TRUST AIA SINGAPORE PARTCIPATING FUND HERITAGE SGD
BSE 11-Oct-2023	Sell BLOCK	844 @ 5563.00	AIA INVESTMENT TRUST AIA SINGAPORE PARTICIPATING FUND HERITAGE USD
BSE 11-Oct-2023	Sell BLOCK	1,567 @ 5563.00	AIA INVESTMENT TRUST AIA SINGAPORE PARTICIPATING FUND USD
BSE 11-Oct-2023	Sell BLOCK	17,633 @ 5563.00	AIA INVESTMENT TRUST-AIA SINGAPORE PARTICIPATING FUND SGD
BSE 11-Oct-2023	Buy BLOCK	96,120 @ 5563.00	AIA VCC - AIA ASIAN EQUITY FUND
BSE 25-Oct-2022	Sell BLOCK	97,226 @ 4377.10	ISHARES CORE EMERGING MARKETS MAURITIUS CO
BSE 25-Oct-2022	Buy BLOCK	97,226 @ 4377.10	ISHARES CORE MSCI EMERGING MARKETS ETF
BSE 17-Oct-2022	Sell BLOCK	152,789 @ 4310.80	ISHARES CORE EMERGING MARKETS MAURITIUS CO
BSE 17-Oct-2022	Buy BLOCK	152,789 @ 4310.80	ISHARES CORE MSCI EMERGING MARKETS ETF
BSE 11-Oct-2022	Sell BLOCK	149,405 @ 4380.00	ISHARES CORE EMERGING MARKETS MAURITIUS CO
BSE 11-Oct-2022	Buy BLOCK	149,405 @ 4380.00	ISHARES CORE MSCI EMERGING MARKETS ETF
BSE 19-Sep-2022	Sell BLOCK	101,622 @ 4077.35	ISHARES CORE EMERGING MARKETS MAURITIUS CO

DIVIDEND BY DR. REDDY'S LABORATORIES LIMITED

Ex Dividend Date	Dividend Type	Dividend
16-Jul-2024	DIVIDEND	40
11-Jul-2023	DIVIDEND	40
11-Jul-2022	DIVIDEND	30
09-Jul-2021	DIVIDEND	25

SPLIT / BONUS BY DR. REDDY'S LABORATORIES LIMITED

Ex Date	Type	Detail
28-Oct-2024	SPLIT	Rs 5 to Rs 1

Data feed Source : www.accordfintech.com, NSE DATA Feed & BSE Data Feed

Facebook

Twitter

To TOP

Dr. Reddy's Laboratories Limited

Dr. Reddy's share price

CONSOLIDATED QUARTERLY RESULT FOR DR. REDDY'S LABORATORIES LIMITED

STANDALONE QUARTERLY RESULT FOR DR. REDDY'S LABORATORIES LIMITED

CONSOLIDATED ANNUAL RESULT FOR DR. REDDY'S LABORATORIES LIMITED

STANDALONE ANNUAL RESULT FOR DR. REDDY'S LABORATORIES LIMITED

CONSOLIDATED PROFIT / LOSS FOR DR. REDDY'S LABORATORIES LIMITED

STANDALONE PROFIT / LOSS FOR DR. REDDY'S LABORATORIES LIMITED

CONSOLIDATED CASH FLOW FOR DR. REDDY'S LABORATORIES LIMITED

STANDALONE CASH FLOW FOR DR. REDDY'S LABORATORIES LIMITED

CONSOLIDATED BALANCE SHEET FOR DR. REDDY'S LABORATORIES LIMITED

STANDALONE BALANCE SHEET FOR DR. REDDY'S LABORATORIES LIMITED

FINANCIAL RATIOS (CONSOLIDATED) FOR DR. REDDY'S LABORATORIES LIMITED

FINANCIAL RATIOS (STANDALONE) FOR DR. REDDY'S LABORATORIES LIMITED

SHARE HOLDING PATTERN FOR DR. REDDY'S LABORATORIES LIMITED

PEER COMPARISON FOR DR. REDDY'S LABORATORIES LIMITED

CORPORATE ACTIONS FOR DR. REDDY'S

CORPORATE ANNOUNCEMENTS FOR DR. REDDY'S

INSIDER TRADING FOR DR. REDDY'S

BULK BLOCK DEALS FOR DR. REDDY'S LABORATORIES LIMITED

DIVIDEND BY DR. REDDY'S LABORATORIES LIMITED

SPLIT / BONUS BY DR. REDDY'S LABORATORIES LIMITED